CPRX icon

Catalyst Pharmaceutical
CPRX

Overview Fund Activity

88 hedge funds and large institutions have $314M invested in Catalyst Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 13 closing their positions.

Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.91%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
15
Increased
25
Reduced
27
Closed
13
Calls
$683K
Puts
$1.19M
Net Calls
-$505K
Net Calls Change
-$424K

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$91.2M
2
OM
2
Opaleye Management
Massachusetts
$9.31M
3
MP
3
Mangrove Partners
Connecticut
$17.6M
4
KCM
4
Kennedy Capital Management
Missouri
$5.1M
5
HRCM
5
Hawk Ridge Capital Management
California
$3.34M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$11.8M
2
BC
2
Broadfin Capital
New York
$29.9M
3
PAM
3
Panagora Asset Management
Massachusetts
$1.52M
4
DMK
4
David M. Knott
$2.61M
5
ARTA
5
A.R.T. Advisors
New York
$59K
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Advisers
101
Two Sigma Advisers
New York
– -$19K -10,000 Closed
1 2 3 4
5